Point72 Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Point72 Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.8M	Buy	177,300 +157,400	+791%	+$9.18M	0.01%	1198
2025 Q4	$1.07M	Sell	19,900 -34,600	-63%	-$1.66M	﹤0.01%	2834
2025 Q3	$2.46M	Buy	+54,500	New	+$2.55M	﹤0.01%	1352
2025 Q2	–	Sell	-17,100	Closed	-$1.04M	–	2202
2025 Q1	$1.04M	Buy	+17,100	New	+$997K	﹤0.01%	1433
2024 Q2	–	Sell	-2,100	Closed	-$114K	–	1888
2024 Q1	$114K	Sell	2,100 -300	-13%	-$15.3K	﹤0.01%	1988
2023 Q4	$123K	Hold	2,400	–	–	﹤0.01%	1907
2023 Q3	$139K	Hold	2,400	–	–	﹤0.01%	1872
2023 Q2	$153K	Sell	2,400 -50,200	-95%	-$3.37M	﹤0.01%	1481
2023 Q1	$3.65M	Sell	52,600 -53,200	-50%	-$3.75M	0.01%	850
2022 Q4	$7.61M	Buy	105,800 +33,700	+47%	+$2.54M	0.03%	634
2022 Q3	$5.13M	Buy	+72,100	New	+$5.23M	0.02%	718
2020 Q3	–	Sell	-1,000,000	Closed	-$58.8M	–	927
2020 Q2	$58.8M	Buy	+1,000,000	New	+$59.8M	0.38%	63
2017 Q3	–	Sell	-500,000	Closed	-$27.9M	–	886
2017 Q2	$27.9M	Buy	+500,000	New	+$27.2M	0.16%	177
2016 Q1	–	Sell	-117,500	Closed	-$8.08M	–	731
2015 Q4	$8.08M	Buy	+117,500	New	+$7.76M	0.07%	338

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's BMY Position: Q1 2026 in Review

Point72 Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 82% in Q1 2026, selling an estimated $144M and leaving 531,198 shares worth $32.2M. The position accounts for 0.04% of the portfolio, ranked #570.

Point72 Asset Management first reported a position in BMY in Q2 2014 and has held it in 33 quarters since. The position peaked at $189M in Q2 2018. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Point72 Asset Management held 531,198 shares of Bristol-Myers Squibb worth $32.2M as of Q1 2026.
Point72 Asset Management sold 2,472,913 Bristol-Myers Squibb shares in Q1 2026, an estimated $144M.
Bristol-Myers Squibb made up 0.04% of Point72 Asset Management's portfolio in Q1 2026, its #570 holding.
Point72 Asset Management first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 33 quarters since.
Point72 Asset Management's Bristol-Myers Squibb position peaked at $189M in Q2 2018.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.